OTLK
Outlook Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.68
+4.48%Margins
Gross margin
195.6%
EBITDA margin
5354.5%
EBIT margin
4783.1%
Net margin
5254.8%
FCF margin
4911.7%
588.1%
Return on equity
-233.4%
Return on assets
-692.1%
Return on invested capital
-0.05x
Asset turnover
-$57.1M
Cash from operations
$0.05
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026